Skip to Content

Why a Birth Control Pill For Men Is Still Not Here

August 3, 2017

Birth control options suffer from a huge gender imbalance, leaving women shouldering most of the load, and men with little besides condoms or a vasectomy to choose from. As a story in Bloomberg today reports, research in male contraception is experiencing a new wave of interest, including one scientist who is resurrecting a compound first investigated in an experiment on prisoners in the 1950's.

But as we have reported, funding for development of "the pill" for men still lags shockingly far behind programs that make contraception avialable to women. That's partly to do with the fact that safely stopping millions of sperm from being produced every day isn't as biologically straightforward as stopping one egg from being released each month. Still, there are researchers out there—not to mention a willing market—who want to help even the playing field, but they're going to need support in order to do it.

Keep Reading

Most Popular

10 Breakthrough Technologies 2024

Every year, we look for promising technologies poised to have a real impact on the world. Here are the advances that we think matter most right now.

Scientists are finding signals of long covid in blood. They could lead to new treatments.

Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.

AI for everything: 10 Breakthrough Technologies 2024

Generative AI tools like ChatGPT reached mass adoption in record time, and reset the course of an entire industry.

What’s next for AI in 2024

Our writers look at the four hot trends to watch out for this year

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.